Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:365-372
Published online before print January 2, 2007, doi: 10.1161/01.HYP.0000255576.16089.b9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/2/365    most recent
01.HYP.0000255576.16089.b9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takemori, K.
Right arrow Articles by Lee, R. M.K.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takemori, K.
Right arrow Articles by Lee, R. M.K.W.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Other etiology
Right arrow Other Vascular biology

(Hypertension. 2007;49:365.)
© 2007 American Heart Association, Inc.


Original Articles

Elevated Blood Pressure in Transgenic Lipoatrophic Mice and Altered Vascular Function

Kumiko Takemori; Yu-Jing Gao; Lili Ding; Chao Lu; Li-Ying Su; Wen-Sheng An; Charles Vinson; Robert M.K.W. Lee

From the Smooth Muscle Research Program and Department of Anesthesia (Y.-J.G., L.D., C.L., L.-Y.S., W.-S.A., R.M.K.W.L.), McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (K.T.), Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan; and the National Cancer Institute (C.V.), National Institutes of Health, Bethesda, Md.

Correspondence to Robert M.K.W. Lee, HSC-2U3, Department of Anaesthesia, McMaster University, 1200 Main St West, Hamilton, Ontario, Canada L8N 3Z5. E-mail rmkwlee{at}mcmaster.ca

The role of perivascular fat in the control of vascular function was studied using lipoatrophic A-ZIP/F1 transgenic mice. Only a small amount of brown fat was found around the aorta but not around mesenteric arteries. Blood pressure of A-ZIP/F1 mice became higher than wild-type (WT) mice from 10 weeks of age. The presence of perivascular fat reduced the contraction of WT aorta to phenylephrine and serotonin, whereas this effect was either absent or less prominent in A-ZIP/F1 aorta. In WT mice, transfer of solution incubated with aorta with fat to aorta with fat removed caused a relaxation response, but not in A-ZIP/F1 mice, indicating the release of a relaxation factor from perivascular fat in WT aorta. This factor was acting through the activation of calcium-dependent potassium channels. Perfusion of phenylephrine to the isolated mesenteric bed caused a higher increase in perfusion pressure in A-ZIP/F1 than in WT mice. Contractile response of aorta to angiotensin II (Ang II) was mediated by Ang II type 1 receptors and was higher in A-ZIP/F1 than in WT mice. Expression of Ang II type 1 receptors but not Ang II type 2 receptors was higher in aorta of A-ZIP/F1 than WT mice. Treatment with an Ang II type 1 receptor antagonist (TCV 116, 10 mg/kg per day) for 2 weeks normalized the blood pressure of A-ZIP/F1 mice. These results suggest that the absence of perivascular fat tissue, which enhances the contractile response of the blood vessels to agonists, and an upregulation of vascular Ang II type 1 receptors in A-ZIP/F1 mice, are some of the mechanisms underlying the blood pressure elevation in these lipoatrophic mice.


Key Words: lipoatrophy • hypertension • vascular fat function • adipose tissue